Implantation or Injectable Dosage Form New Animal Drugs; Flunixin Meglumine
other · Food and Drug Administration · Rule · Published 1998-07-20 · Effective 1998-07-20 · 63 FR 38749
Document
Document number
98-19176
Federal Register citation
63 FR 38749
CFR reference
21 CFR 522
Type
Rule
Action
Final rule.
Category
other
Sub-agency
Food and Drug Administration
Publication date
1998-07-20
Effective date
1998-07-20
Abstract
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Schering-Plough Animal Health Corp. The supplemental NADA provides for veterinary prescription use of flunixin meglumine solution, intravenously, for control of pyrexia associated with bovine respiratory disease and endotoxemia, and control of inflammation in endotoxemia, in beef and nonlactating dairy cattle.